Sign In To Continue
You have reached the guest article limit.
Unlock more IIPLA analysis by signing in with SSO or joining as a member.
By examining litigation records over the past decade, we set out to identify which products, active ingredients, therapeutic indications, and patents have been most frequently asserted—and to pinpoint areas ripe for future contention. To stay ahead of litigation trends in fast-evolving industries, WIT analyzes its cor…